| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |